Thoma Bravo closes MedeAnalytics buy

Thoma Bravo has completed its buy of MedeAnalytics Inc. Financial terms weren’t announced. Prior investors Bain Capital Ventures and Emergence Capital Partners will remain minority shareholders. MedeAnalytics provides cloud-based financial performance analytics for the healthcare industry.

1 October 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles